Загрузка...
Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy
OBJECTIVE: Hypothyroidism is relatively common, occurring in approximately 5% of the general US population aged ≥12 years. Levothyroxine (LT4) monotherapy is the standard of care. Approximately, 5%‐10% of patients who normalise thyroid‐stimulating hormone levels with LT4 monotherapy may have persist...
Сохранить в:
| Опубликовано в: : | Int J Clin Pract |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5873391/ https://ncbi.nlm.nih.gov/pubmed/29381251 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.13062 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|